Evidence review: social marketing for the prevention and control of communicable disease
This report provides a summary of social marketing for the prevention and control of communicable disease, with particular reference to the European context. It concludes that the international evidence base shows that social marketing can be an effective approach to behaviour change, and although the European evidence is limited, there have been some promising efforts in the area of hand hygiene and sexual health interventions.
As part of its ‘Insights into Health Communication’ series, ECDC has published an evidence review on the use of social marketing for the prevention and control of communicable disease, with a particular emphasis on the European context.
The report shows how social marketing principles have been successfully applied in hand hygiene and sexual health interventions, as well as highlighting the challenges ahead. It also offers insights for policy and practice such as the use of social marketing research methods in message development and dissemination.
Five international reviews and three European reviews were included in the report and include established, emergent and innovative practice.
An overview of the rapid test situation for COVID-19 diagnosis in the EU/EEA
1 Apr 2020 - According to EU recommendations, timely and accurate COVID-19 laboratory testing is an essential part of the management of COVID-19 for slowing down the pandemic, supporting decisions on infection control strategies and patient management at healthcare facilities, and detecting asymptomatic cases that could spread the virus further if not isolated.
Contact tracing: Public health management of persons, including healthcare workers, having had contact with COVID-19 cases in the European Union – second update
31 Mar 2020 - This document outlines the key steps of contact tracing, including contact identification, listing and follow-up, in the context of the COVID-19 response.
Infection prevention and control and preparedness for COVID-19 in healthcare settings
31 Mar 2020 - This document aims to provide guidance to EU/EEA healthcare facilities and healthcare providers on infection prevention and control (IPC) measures for the management of suspected and confirmed cases of COVID-19 infection in healthcare settings, including long-term care facilities. It also offers guidance on the management of specimens at laboratories in the EU/EEA.